Total Payments
$11,893
2024 Payments
$104.36
Companies
51
Transactions
427
Medicare Patients
2,951
Medicare Billing
$446,118
Payment Breakdown by Category
Food & Beverage$7,627 (64.1%)
Other$4,219 (35.5%)
Education$30.84 (0.3%)
Gifts$16.82 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,627 | 411 | 64.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,219 | 13 | 35.5% |
| Education | $30.84 | 2 | 0.3% |
| Gift | $16.82 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $4,513 | 24 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $770.68 | 43 | $0 (2020) |
| Allergan, Inc. | $614.28 | 51 | $0 (2021) |
| Biogen, Inc. | $533.30 | 28 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $497.21 | 32 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $488.03 | 15 | $0 (2020) |
| UCB, Inc. | $471.91 | 21 | $0 (2023) |
| EMD Serono, Inc. | $390.75 | 22 | $0 (2020) |
| Genentech USA, Inc. | $352.76 | 22 | $0 (2020) |
| Amgen Inc. | $310.17 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.36 | 4 | Lundbeck LLC ($45.78) |
| 2023 | $193.47 | 7 | AbbVie Inc. ($97.51) |
| 2022 | $99.37 | 5 | SK Life Science, Inc. ($25.65) |
| 2021 | $228.62 | 11 | Allergan, Inc. ($132.25) |
| 2020 | $850.93 | 43 | Biogen, Inc. ($100.03) |
| 2019 | $2,499 | 133 | Novartis Pharmaceuticals Corporation ($416.31) |
| 2018 | $1,908 | 113 | Novartis Pharmaceuticals Corporation ($201.60) |
| 2017 | $6,009 | 111 | Supernus Pharmaceuticals, Inc. ($4,225) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $35.33 | General |
| 04/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.21 | General |
| Category: NEUROLOGY | ||||||
| 02/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neurology | ||||||
| 02/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: NEUROLOGY | ||||||
| 11/17/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Neurology | ||||||
| 07/13/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2023 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Neuroscience | ||||||
| 04/14/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/18/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/14/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: PRIMARY CARE | ||||||
| 06/28/2022 | LivaNova USA, Inc. | VNS Therapy SenTiva Model 1000 Generator (Device) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/07/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.65 | General |
| 02/03/2022 | Aprecia Pharmaceuticals, LLC | Spritam (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Decrease CNS Disorganized Electrical Activity [PE] | ||||||
| 12/16/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/15/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: HYPERHYDROSIS | ||||||
| 12/01/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2021 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 07/19/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/03/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/20/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.11 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/04/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 601 | 8,208 | $251,016 | $85,860 |
| 2022 | 9 | 576 | 7,092 | $236,423 | $80,210 |
| 2021 | 16 | 816 | 13,543 | $368,236 | $129,575 |
| 2020 | 21 | 958 | 14,919 | $446,303 | $150,474 |
Total Patients
2,951
Total Services
43,762
Medicare Billing
$446,118
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 7,535 | $105,490 | $36,707 | 34.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 181 | 188 | $55,836 | $18,379 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 164 | 233 | $35,882 | $13,658 | 38.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 133 | 139 | $16,819 | $5,917 | 35.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 47 | $20,539 | $5,712 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 28 | $6,188 | $2,309 | 37.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 13 | 13 | $6,279 | $1,949 | 31.0% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 12 | 13 | $2,483 | $724.68 | 29.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 12 | 12 | $1,500 | $504.35 | 33.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 13 | 6,470 | $90,580 | $31,296 | 34.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 171 | 175 | $51,975 | $17,251 | 33.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 65 | 65 | $28,405 | $9,119 | 32.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 93 | 133 | $20,482 | $7,381 | 36.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 113 | 118 | $14,278 | $5,285 | 37.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 37 | $8,177 | $2,886 | 35.3% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 27 | 27 | $8,316 | $2,478 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 33 | $7,590 | $2,253 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 18 | $4,140 | $1,296 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $2,480 | $966.31 | 39.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 17 | 12,600 | $173,043 | $59,295 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 137 | $31,510 | $11,686 | 37.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 127 | 169 | $26,026 | $9,280 | 35.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 72 | 73 | $21,681 | $7,604 | 35.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 152 | 161 | $19,481 | $7,158 | 36.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 98 | $15,190 | $5,472 | 36.0% |
About Dr. Sandra Crouse, MD
Dr. Sandra Crouse, MD is a Neurology healthcare provider based in Fredericksburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164631255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Crouse, MD has received a total of $11,893 in payments from pharmaceutical and medical device companies, with $104.36 received in 2024. These payments were reported across 427 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($7,627).
As a Medicare-enrolled provider, Crouse has provided services to 2,951 Medicare beneficiaries, totaling 43,762 services with total Medicare billing of $446,118. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Fredericksburg, VA
- Active Since 05/22/2007
- Last Updated 12/13/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164631255
Products in Payments
- OXTELLAR XR (Drug) $4,177
- APTIOM (Drug) $497.21
- SOLIRIS (Drug) $454.20
- BOTOX (Biological) $442.17
- OCREVUS (Biological) $338.19
- TROKENDI XR (Drug) $335.85
- AIMOVIG (Biological) $318.84
- TECFIDERA (Drug) $314.76
- Aimovig (Biological) $293.67
- Vimpat (Drug) $264.34
- Rebif (Biological) $212.24
- AUBAGIO (Drug) $199.55
- Briviact (Drug) $189.43
- Fycompa (Drug) $182.10
- TYSABRI (Biological) $175.46
- AMPYRA (Drug) $168.67
- GILENYA (Drug) $164.19
- Hizentra (Biological) $161.14
- MAYZENT (Drug) $155.30
- AJOVY (Drug) $146.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fredericksburg
Dr. Dale Pcsolyar, M.d, M.D
Neurology — Payments: $109,051
Neurology $109,051
Barbara Decker, Md, MD
Neurology — Payments: $38,238
Neurology $38,238
Dr. Matthew Stotz, M.d, M.D
Neurology — Payments: $10,055
Neurology $10,055
Ronald Stotz, Md, MD
Neurology — Payments: $8,917
Neurology $8,917
Theresa Weber, Md, MD
Neurology — Payments: $4,580
Neurology $4,580
Dr. Richard Erwin, M.d, M.D
Neurology — Payments: $2,730
Neurology $2,730